Prescribing of flupirtine in IMS Disease Analyser in Germany (Flupirtine drug utilisation in Germany)

Study identification

• EU PAS number:
  EUPAS33919
• Study ID:
  33920
• Official title and acronym:
  Prescribing of flupirtine in IMS Disease Analyser in Germany (Flupirtine drug utilisation in Germany)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  The study identifies specialist categories that prescribe flupirtine. The age and gender distribution of patients is analysed among flupirtine prescriptions. The total number of patients with a prescription, and the number of patients with a first prescription for flupirtine is then analysed over time between 2010 and June 2017 (yearly and halfyearly) in GP and orthopedic practices.
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned:13/07/2017

Actual:13/07/2017

Study start date

Planned:29/08/2017

Actual:29/08/2017

Data analysis start date

Planned:29/08/2017

Actual:29/08/2017

Date of final study report

Planned:29/08/2017

Actual:29/08/2017

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable